KRAS mutation allele frequency threshold alters prognosis in right‐sided resected pancreatic cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KRAS mutation allele frequency threshold alters prognosis in right‐sided resected pancreatic cancer
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-03-25
DOI
10.1002/jso.26860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma
- (2021) Cara Kenney et al. INVESTIGATIONAL NEW DRUGS
- Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
- (2021) Alice Indini et al. Pharmaceutics
- Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
- (2021) Jun Ushio et al. Diagnostics
- Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival
- (2021) Giulio Belfiori et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting KRAS in pancreatic cancer: new drugs on the horizon
- (2021) Sahar F. Bannoura et al. CANCER AND METASTASIS REVIEWS
- Homologous recombination repair gene mutations in Chinese pancreatic ductal adenocarcinoma patients.
- (2021) Nengwen Ke et al. JOURNAL OF CLINICAL ONCOLOGY
- Confirming putative variants at ≤ 5% allele frequency using allele enrichment and Sanger sequencing
- (2021) Yan Helen Yan et al. Scientific Reports
- Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
- (2020) Joanne M. Mankor et al. BRITISH JOURNAL OF CANCER
- The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia
- (2020) David C. Linch et al. BRITISH JOURNAL OF HAEMATOLOGY
- Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
- (2020) Michael J Pishvaian et al. LANCET ONCOLOGY
- Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
- (2020) Fumiaki Watanabe et al. PLoS One
- Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands
- (2020) Lois A. Daamen et al. ANNALS OF SURGERY
- Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
- (2020) Kanchan Singh et al. LABORATORY INVESTIGATION
- KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
- (2020) David S. Hong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
- (2020) Matilda Holm et al. PLoS One
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?
- (2019) Tamara M.H. Gall et al. Oncotarget
- Analysis of heritability and genetic architecture of Pancreatic Cancer: A PanC4 Study
- (2019) Fei Chen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Next-Generation Sequencing in Pancreatic Cancer
- (2019) Gong-Qing Shen et al. PANCREAS
- The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer
- (2019) Weng et al. Journal of Clinical Medicine
- Impact of the variant allele frequency of ASXL1 , DNMT3A , JAK2 , TET2 , TP53 , and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia
- (2019) Koji Sasaki et al. CANCER
- Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer
- (2019) Sumitra Mohan et al. Scientific Reports
- Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
- (2018) Vincent P. Groot et al. ANNALS OF SURGICAL ONCOLOGY
- Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome
- (2018) Mayinuer Alifu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- KRAS -Mutant Non-Small Cell Lung Cancer: From Biology to Therapy
- (2018) Irene Ferrer et al. LUNG CANCER
- Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection
- (2018) Lianhua Dong et al. Scientific Reports
- Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma
- (2018) Jie Ma et al. BMC CANCER
- Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
- (2017) Koji Shindo et al. JOURNAL OF CLINICAL ONCOLOGY
- Current and future therapies for advanced pancreatic cancer
- (2017) Rohan Gupta et al. JOURNAL OF SURGICAL ONCOLOGY
- Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993–2013
- (2017) Talia Golan et al. Journal of the National Comprehensive Cancer Network
- Prevalence and detection of low-allele-fraction variants in clinical cancer samples
- (2017) Hyun-Tae Shin et al. Nature Communications
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
- (2017) Andrew M. Waters et al. Cold Spring Harbor Perspectives in Medicine
- Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals
- (2017) Ligang Xia et al. Scientific Reports
- Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer
- (2016) Irina Heid et al. CLINICAL CANCER RESEARCH
- Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
- (2016) Alexander A. Parikh et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- KRAS-related proteins in pancreatic cancer
- (2016) Karen M. Mann et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients
- (2015) C. Hu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Allelic Ratio of KRAS Mutations in Pancreatic Cancer
- (2015) J. K. Lennerz et al. ONCOLOGIST
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing
- (2014) Ming-Tseh Lin et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation
- (2014) A. Ono et al. ANNALS OF ONCOLOGY
- Molecular pathology of pancreatic cancer
- (2014) Yuriko Saiki et al. PATHOLOGY INTERNATIONAL
- Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma
- (2012) Dong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas
- (2012) Nicolai Aagaard Schultz et al. PANCREAS
- A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis
- (2011) C A Whipple et al. ONCOGENE
- Genome-wide Significant Associations for Variants With Minor Allele Frequency of 5% or Less—An Overview: A HuGE Review
- (2010) Orestis A. Panagiotou et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
- (2010) Jennifer P. Morton et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started